Cargando…

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

BACKGROUND: Alpha-synuclein (α-syn) is considered the main pathophysiological protein component of Lewy bodies in synucleinopathies. α-Syn is an intrinsically disordered protein (IDP), and several types of structural conformations have been reported, depending on environmental factors. Since IDPs ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Kyu Hwan, Kang, Min Ju, Youn, Young Chul, An, Seong Soo A., Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805257/ https://www.ncbi.nlm.nih.gov/pubmed/36587215 http://dx.doi.org/10.1186/s13195-022-01150-0

Ejemplares similares

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
por: Shim, Kyu Hwan, et al.
Publicado: (2020)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

The genetics of Alzheimer’s disease
por: Bagyinszky, Eva, et al.
Publicado: (2014)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
por: Bagyinszky, Eva, et al.
Publicado: (2016)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Whole Exome Sequencing Reveals a Novel APOE Mutation in a Patient With Sporadic Early-Onset Alzheimer's Disease
por: Bagaria, Jaya, et al.
Publicado: (2022)

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
por: Thomzig, Achim, et al.
Publicado: (2014)

Cerebrospinal Fluid Amyloid β(1-42), Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s Disease
por: Kang, Ju-Hee
Publicado: (2016)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

Probable novel PSEN2 Val214Leu mutation in Alzheimer’s disease supported by structural prediction
por: Youn, Young Chul, et al.
Publicado: (2014)

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
por: Shim, Kyu Hwan, et al.
Publicado: (2021)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
por: Shim, Kyu Hwan, et al.
Publicado: (2021)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Ubiquilin-2 regulates pathological alpha-synuclein
por: Sandoval-Pistorius, Stephanie S., et al.
Publicado: (2023)

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
por: Park, Sun Ah, et al.
Publicado: (2020)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
por: Chen, Yun-Hsiang, et al.
Publicado: (2021)

Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
por: Mendritzki, Sonja, et al.
Publicado: (2010)

Pathological alpha-synuclein propagates through neural networks
por: Masuda-Suzukake, Masami, et al.
Publicado: (2014)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies
por: Fixemer, Sonja, et al.
Publicado: (2022)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease
por: Lee, Hyun‐ju, et al.
Publicado: (2021)

Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease
por: Vacchi, Elena, et al.
Publicado: (2021)

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
por: Rousseaux, Maxime WC, et al.
Publicado: (2016)

Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core
por: Vacchi, Elena, et al.
Publicado: (2020)

Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum
por: Zinnen, Alexandra D., et al.
Publicado: (2022)

Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau
por: Gracia, Pablo, et al.
Publicado: (2022)

Novel PSEN1 G209A mutation in early-onset Alzheimer dementia supported by structural prediction
por: An, Seong Soo A., et al.
Publicado: (2016)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai, Yan, et al.
Publicado: (2015)

A Comprehensive Visual Rating Scale for Predicting Progression from Mild Cognitive Impairment to Dementia in Patients with Alzheimer's Pathology or Suspected Non-Alzheimer's Pathology
por: Park, Sang Won, et al.
Publicado: (2020)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Kelly, Rachel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jhskhapi26oo0757gca0k3r76